HubSpot, Inc. HUBS reported stronger-than-expected outcomes for its fourth quarter on Wednesday.
HubSpot reported quarterly earnings of $2.32 per share, beating the $2.19 analysts consensus estimate. Quarterly income got here in at $703.17 million, beating the $673.32 million consensus estimate.
“We had a strong end to 2024, highlighting our management as a platform firm”, mentioned Yamini Rangan, CEO of HubSpot. “2024 was a transformative yr for HubSpot as we reimagined our product, our platform, and firm with AI. I am excited by the progress we have made in embedding AI throughout our hubs and the worth it is driving for patrons.”
The corporate mentioned it sees first-quarter income of between $697 million and $699 million, versus the $705.71 million estimate, and EPS of between $1.74 and $1.76, versus the $2.00 estimate
HubSpot shares gained 0.1% to shut at $785.50 on Wednesday.
These analysts made adjustments to their worth targets on HubSpot following earnings announcement.
- Oppenheimer analyst Ken Wong maintained HubSpot with an Outperform and raised the value goal from $850 to $900.
- Piper Sandler analyst Brent Bracelin maintained HubSpot with a Impartial and raised the value goal from $640 to $808.
- Canaccord Genuity analyst David Hynes maintained the inventory with a Purchase and raised the value goal from $710 to $900.
- Morgan Stanley analyst Keith Weiss maintained HubSpot with an Chubby and boosted the value goal from $835 to $898.
- Barclays analyst Ryan Macwilliams maintained the inventory with an Equal-Weight and raised the value goal from $725 to $815.
- Needham analyst Joshua Reilly maintained HubSpot with a Purchase and raised the value goal from $730 to $900.
- Truist Securities analyst Terry Tillman reiterated the inventory with a Purchase and raised the value goal from $750 to $900.
Contemplating shopping for HUBS inventory? Right here’s what analysts assume:
Learn This Subsequent:
Market Information and Information dropped at you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
